Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 22, 2008. The document serves as a report regarding special resolutions passed at the Company's Annual General Meeting (AGM) held on May 21, 2008.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding corporate governance resolutions rather than a financial results report.
Material Changes
No material financial changes versus the prior comparable period are disclosed in this text. The filing confirms that two copies of all resolutions passed under special business at the AGM have been submitted to the UK Listing Authority.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It solely addresses the administrative submission of AGM resolutions.
Key Facts for Investors
- The filing documents special resolutions passed at the AGM on May 21, 2008.
- Resolutions have been submitted to the UK Listing Authority and are available for inspection via the Document Viewing Facility at the Financial Services Authority in London.
- This document contains no financial performance data or forward-looking statements.